Silver Book Fact

A blood thinning drug was found to reduce the risk of heart attack, stroke, and cardiovascular disease by 20% in patients with acute coronary syndrome when given in addition to aspirin.

Salim, Yusuf, D. Phil, Feng Zhao, Shamir R. Mehta, Susan Chrolavicius, Gianni Tognoni, and Keith K. Fox. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. N Engl J Med. 2001; 345(7): 494-502. http://content.nejm.org/cgi/content/abstract/345/7/494

Reference

Title
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
Publication
N Engl J Med
Publication Date
2001
Authors
Salim, Yusuf, D. Phil, Feng Zhao, Shamir R. Mehta, Susan Chrolavicius, Gianni Tognoni, and Keith K. Fox
Volume & Issue
Volume 345, Issue 7
Pages
494-502
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • According to the National Center for Health Statistics, if all major forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.  
  • From 1979 to 2005, the total number of inpatient cardiovascular operations and procedures increased 484% to 6,989,000 annually.  
  • Without antihypertensive drug therapy, there would have been about 572,000 more hospital discharges for stroke in 2002 and 261,000 more discharges for myocardial infarction.  
  • “Over the past thirty-five years, U.S. age-adjusted mortality from cardiovascular disease declined 50 percent. This marked reduction reflects advances in the prevention, diagnosis, and treatment of common cardiovascular conditions.”